A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia.
Sawa M, Miyamoto T, Kim HJ, Hiramatsu Y, Cheong JW, Ikezoe T, Naoe T, Akashi K, Morita S, Kosako M, Ikegaya M, Terada W, Kadokura T, Hill J, Miyawaki S, Gill SC, Heinloth A, Hasabou N.
Sawa M, et al. Among authors: naoe t.
Int J Hematol. 2025 Jan;121(1):56-67. doi: 10.1007/s12185-024-03840-x. Epub 2024 Nov 6.
Int J Hematol. 2025.
PMID: 39503987
Free PMC article.
Clinical Trial.